These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38417047)

  • 21. PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease?
    Machado CM; Leite NC; França PH; Cardoso CR; Salles GF; Villela-Nogueira CA
    Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):965-971. PubMed ID: 31377187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Zhou K; Dodge JL; Yuan L; Terrault NA
    Dig Dis Sci; 2022 Jul; 67(7):3340-3355. PubMed ID: 34173916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus.
    Gupta A; Anoop S; Ansari IA; Prakash S; Misra A
    Clin Nutr ESPEN; 2021 Dec; 46():519-526. PubMed ID: 34857244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes.
    Ciardullo S; Monti T; Perseghin G
    Diabetes Care; 2021 Feb; 44(2):519-525. PubMed ID: 33303638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
    Noureddin M; Wong MM; Todo T; Lu SC; Sanyal AJ; Mena EA
    World J Gastroenterol; 2018 Mar; 24(11):1269-1277. PubMed ID: 29568207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Nobarani S; Alaei-Shahmiri F; Aghili R; Malek M; Poustchi H; Lahouti M; Khamseh ME
    Dig Dis Sci; 2022 Apr; 67(4):1389-1398. PubMed ID: 33788095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.
    Casey SP; Kemp WW; McLean CA; Topliss DJ; Adams LA; Roberts SK
    Scand J Gastroenterol; 2012 Jul; 47(7):836-41. PubMed ID: 22519948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study.
    van Kleef LA; Ayada I; Alferink LJM; Pan Q; de Knegt RJ
    Hepatology; 2022 Feb; 75(2):419-429. PubMed ID: 34453359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of glycated hemoglobin with non-alcoholic fatty liver disease patients and the severity of liver steatosis and fibrosis measured by transient elastography in adults without diabetes.
    Xie Y; Kong W; Wang X; Wu Z
    BMC Endocr Disord; 2022 Aug; 22(1):220. PubMed ID: 36045348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
    Behairy MA; Sherief AF; Hussein HA
    Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
    Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment.
    Niyasom C; Soponkanaporn S; Vilaiyuk S; Lertudomphonwanit C; Getsuwan S; Tanpawpong P; Kaewduang P; Sobhonslidsuk A
    Clin Rheumatol; 2024 Jan; 43(1):423-433. PubMed ID: 38062311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus.
    Zhao H; Song X; Li Z; Wang X
    Medicine (Baltimore); 2018 Sep; 97(37):e12356. PubMed ID: 30212992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.
    Myers RP; Elkashab M; Ma M; Crotty P; Pomier-Layrargues G
    Can J Gastroenterol; 2010 Nov; 24(11):661-70. PubMed ID: 21157581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
    Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
    Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study.
    Makker J; Tariq H; Kumar K; Ravi M; Shaikh DH; Leung V; Hayat U; Hassan MT; Patel H; Nayudu S; Chilimuri S
    World J Gastroenterol; 2021 Feb; 27(6):523-533. PubMed ID: 33642826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.
    Hydes T; Brown E; Hamid A; Bateman AC; Cuthbertson DJ
    Clin Ther; 2021 Sep; 43(9):1505-1522. PubMed ID: 34400007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
    Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA;
    HIV Med; 2024 Jan; 25(1):95-106. PubMed ID: 37670375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.